Latigo Biotherapeutics, Inc. (LTGO)
12.50
-0.51
(-3.92%)
USD |
NASDAQ |
Nov 06, 10:20
Latigo Biotherapeutics EPS Diluted (Quarterly) : -0.3891 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3891 |
| March 31, 2026 | -0.3631 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.4085 |
| March 31, 2025 | -0.3313 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Turn Therapeutics, Inc. | -0.1964 |
| Journey Medical Corp. | -0.0114 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.80M |
| Total Expenses (Quarterly) | 25.80M |
| Enterprise Value | 1.127B |
| Earnings Yield | -11.94% |
| Normalized Earnings Yield | -11.86 |